Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Colorcon
Baxter
McKesson
Medtronic

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Moclobemide

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Moclobemide: Sponsors, patents, clinical trial progress

Moclobemide is an investigational drug.

There have been 6 clinical trials for Moclobemide. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2005.

The most common disease conditions in clinical trials are Sialorrhea, Depression, and Disease. The leading clinical trial sponsors are Beersheva Mental Health Center, Tirat Carmel Mental Health Center, and Hannover Medical School.

Recent Clinical Trials for Moclobemide
TitleSponsorPhase
Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancerChina Medical University HospitalPhase 2
Pharmacovigilance in Gerontopsychiatric PatientsHannover Medical SchoolPhase 3
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female SmokersNational Institute on Drug Abuse (NIDA)Phase 2

See all Moclobemide clinical trials

Clinical Trial Summary for Moclobemide

Top disease conditions for Moclobemide
Top clinical trial sponsors for Moclobemide

See all Moclobemide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Express Scripts
Johnson and Johnson
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.